Sep 14 |
Arvinas (NASDAQ:ARVN) shareholders have endured a 74% loss from investing in the stock three years ago
|
Sep 12 |
Vanguard Group Inc's Strategic Acquisition of Arvinas Inc Shares
|
Sep 5 |
Arvinas, Inc. (ARVN): This Small-Cap Healthcare Stock Is A Good Buy Right Now
|
Aug 4 |
Brokers Are Upgrading Their Views On Arvinas, Inc. (NASDAQ:ARVN) With These New Forecasts
|
Aug 1 |
Arvinas, Inc. (NASDAQ:ARVN) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
|
Jul 30 |
Arvinas, Inc. (ARVN) Reports Q2 Loss, Tops Revenue Estimates
|
Jul 30 |
Arvinas GAAP EPS of -$0.49 beats by $0.09, revenue of $76.5M beats by $5.98M
|
Jul 30 |
Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
Jul 22 |
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
|
Jul 17 |
Biotech Arvinas Stock Earns 82 RS Rating
|